BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17322156)

  • 1. Jere Goyan, only pharmacist to lead FDA, dies at 76.
    Traynor K
    Am J Health Syst Pharm; 2007 Mar; 64(5):459. PubMed ID: 17322156
    [No Abstract]   [Full Text] [Related]  

  • 2. Remembering Jere Goyan.
    Sasich LD
    Am J Health Syst Pharm; 2007 Jun; 64(11):1142. PubMed ID: 17519452
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA law enforcement: critical to product safety.
    Rados C
    FDA Consum; 2006; 40(1):21-7. PubMed ID: 16528823
    [No Abstract]   [Full Text] [Related]  

  • 6. Jere Edwin Goyan 1930-2007: proponent of expanding pharmacists' role.
    Worthen DB
    J Am Pharm Assoc (2003); 2008; 48(1):101-4. PubMed ID: 18192138
    [No Abstract]   [Full Text] [Related]  

  • 7. A century of ensuring safe foods and cosmetics.
    Meadows M
    FDA Consum; 2006; 40(1):6-13. PubMed ID: 16528821
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA-483: history and use in drug inspections.
    Cooper D
    PDA J Pharm Sci Technol; 1996; 50(6):386-90. PubMed ID: 9038085
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and Drug Administration: 100 years of protection.
    Mosocco DJ
    Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
    [No Abstract]   [Full Text] [Related]  

  • 10. Learning about the safety of drugs--a half-century of evolution.
    Avorn J
    N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA ten years after the Kefauver-Harris amendments.
    Hollister LE
    Perspect Biol Med; 1974; 17(2):243-9. PubMed ID: 4591497
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigations and reports respecting FDA regulation of new drugs (Part I).
    Hutt PB
    Clin Pharmacol Ther; 1983 Apr; 33(4):537-48. PubMed ID: 6339149
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigations and reports respecting FDA regulation of new drugs (Part II).
    Hutt PB
    Clin Pharmacol Ther; 1983 May; 33(5):674-87. PubMed ID: 6340910
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey Amendment of 1951.
    Swann JP
    Pharm Hist; 1994; 36(2):55-70. PubMed ID: 11613485
    [No Abstract]   [Full Text] [Related]  

  • 15. The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay.
    Hutt PB
    Am J Law Med; 2018 May; 44(2-3):403-451. PubMed ID: 30106657
    [No Abstract]   [Full Text] [Related]  

  • 16. The short happy life of the first pharmacology division of the FDA: 1935-1936.
    Farrar GE
    Clin Ther; 1989; 11(1):183-4. PubMed ID: 2655903
    [No Abstract]   [Full Text] [Related]  

  • 17. The Food and Drug Administration: how those regulations came to be.
    Ziporyn T
    JAMA; 1985 Oct; 254(15):2037-9, 2043-6. PubMed ID: 3900441
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulating Homeopathic Products - A Century of Dilute Interest.
    Podolsky SH; Kesselheim AS
    N Engl J Med; 2016 Jan; 374(3):201-3. PubMed ID: 26789866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conversation with Commissioner Jere E. Goyan, pharmacist. Interview by William E. Small.
    Goyan JE
    Am Pharm; 1980 Jan; NS20(1):19-24. PubMed ID: 7378168
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA centennial.
    Kennedy D
    Science; 2006 Apr; 312(5770):19. PubMed ID: 16601155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.